Modelling the Regulation of Telomere Length: the Effects of Telomerase and G-quadruplex Stabilising Drugs

Overview

Journal J Math Biol

Date 2013 Apr 27

PMID 23620229

Citations 4

Authors

Bartholomaus V Hirt

Jonathan A D Wattis

Simon P Preston

Affiliations

Soon will be listed here.

Abstract

Telomeres are guanine-rich sequences at the end of chromosomes which shorten during each replication event and trigger cell cycle arrest and/or controlled death (apoptosis) when reaching a threshold length. The enzyme telomerase replenishes the ends of telomeres and thus prolongs the life span of cells, but also causes cellular immortalisation in human cancer. G-quadruplex (G4) stabilising drugs are a potential anticancer treatment which work by changing the molecular structure of telomeres to inhibit the activity of telomerase. We investigate the dynamics of telomere length in different conformational states, namely t-loops, G-quadruplex structures and those being elongated by telomerase. By formulating deterministic differential equation models we study the effects of various levels of both telomerase and concentrations of a G4-stabilising drug on the distribution of telomere lengths, and analyse how these effects evolve over large numbers of cell generations. As well as calculating numerical solutions, we use quasicontinuum methods to approximate the behaviour of the system over time, and predict the shape of the telomere length distribution. We find those telomerase and G4-concentrations where telomere length maintenance is successfully regulated. Excessively high levels of telomerase lead to continuous telomere lengthening, whereas large concentrations of the drug lead to progressive telomere erosion. Furthermore, our models predict a positively skewed distribution of telomere lengths, that is, telomeres accumulate over lengths shorter than the mean telomere length at equilibrium. Our model results for telomere length distributions of telomerase-positive cells in drug-free assays are in good agreement with the limited amount of experimental data available.

Citing Articles

Synthesis and Molecular Dynamic Simulation of Novel Cationic and Non-cationic Pyrimidine Derivatives as Potential G-quadruplex-ligands.

Atapour-Mashhad H, Soukhtanloo M, Golmohammadzadeh S, Chamani J, Nejabat M, Hadizadeh F Anticancer Agents Med Chem. 2024; 24(15):1126-1141.

PMID: 38840398 DOI: 10.2174/0118715206291797240523112439.

Mathematical modelling of telomere length dynamics.

Wattis J, Qi Q, Byrne H J Math Biol. 2019; 80(4):1039-1076.

PMID: 31728621 PMC: 7028829. DOI: 10.1007/s00285-019-01448-y.

Evaluating biomarkers to model cancer risk post cosmic ray exposure.

Sridharan D, Asaithamby A, Blattnig S, Costes S, Doetsch P, Dynan W Life Sci Space Res (Amst). 2016; 9:19-47.

PMID: 27345199 PMC: 5613937. DOI: 10.1016/j.lssr.2016.05.004.

Stochastic simulations of normal aging and Werner's syndrome.

Qi Q, Wattis J, Byrne H Bull Math Biol. 2014; 76(6):1241-69.

PMID: 24771273 PMC: 4048474. DOI: 10.1007/s11538-014-9952-8.

References

Lei M, Zaug A, Podell E, Cech T . Switching human telomerase on and off with hPOT1 protein in vitro. J Biol Chem. 2005; 280(21):20449-56. DOI: 10.1074/jbc.M502212200. View

Wu P, de Lange T . Human telomerase caught in the act. Cell. 2009; 138(3):432-4. DOI: 10.1016/j.cell.2009.07.018. View

Hirt B, Wattis J, Preston S, Laughton C . The effects of a telomere destabilizing agent on cancer cell-cycle dynamics--integrated modelling and experiments. J Theor Biol. 2011; 295:9-22. DOI: 10.1016/j.jtbi.2011.10.038. View

de Lange T . How telomeres solve the end-protection problem. Science. 2009; 326(5955):948-52. PMC: 2819049. DOI: 10.1126/science.1170633. View

Rodriguez-Brenes I, Peskin C . Quantitative theory of telomere length regulation and cellular senescence. Proc Natl Acad Sci U S A. 2010; 107(12):5387-92. PMC: 2851797. DOI: 10.1073/pnas.0914502107. View

de Lange T . T-loops and the origin of telomeres. Nat Rev Mol Cell Biol. 2004; 5(4):323-9. DOI: 10.1038/nrm1359. View

Abdallah P, Luciano P, Runge K, Lisby M, Geli V, Gilson E . A two-step model for senescence triggered by a single critically short telomere. Nat Cell Biol. 2009; 11(8):988-93. PMC: 4025917. DOI: 10.1038/ncb1911. View

Zaug A, Podell E, Cech T . Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro. Proc Natl Acad Sci U S A. 2005; 102(31):10864-9. PMC: 1180509. DOI: 10.1073/pnas.0504744102. View

Takai H, Smogorzewska A, de Lange T . DNA damage foci at dysfunctional telomeres. Curr Biol. 2003; 13(17):1549-56. DOI: 10.1016/s0960-9822(03)00542-6. View

10.

Makarov V, Hirose Y, Langmore J . Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell. 1997; 88(5):657-66. DOI: 10.1016/s0092-8674(00)81908-x. View

11.

Teixeira M, Arneric M, Sperisen P, Lingner J . Telomere length homeostasis is achieved via a switch between telomerase- extendible and -nonextendible states. Cell. 2004; 117(3):323-35. DOI: 10.1016/s0092-8674(04)00334-4. View

12.

Kimura M, Stone R, Hunt S, Skurnick J, Lu X, Cao X . Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths. Nat Protoc. 2010; 5(9):1596-607. DOI: 10.1038/nprot.2010.124. View

13.

Wallweber G, Gryaznov S, Pongracz K, Pruzan R . Interaction of human telomerase with its primer substrate. Biochemistry. 2003; 42(2):589-600. DOI: 10.1021/bi026914a. View

14.

Dai X, Huang C, Bhusari A, Sampathi S, Schubert K, Chai W . Molecular steps of G-overhang generation at human telomeres and its function in chromosome end protection. EMBO J. 2010; 29(16):2788-801. PMC: 2924643. DOI: 10.1038/emboj.2010.156. View

15.

Blackburn E . Switching and signaling at the telomere. Cell. 2001; 106(6):661-73. DOI: 10.1016/s0092-8674(01)00492-5. View

16.

Kim N, Piatyszek M, Prowse K, Harley C, WEST M, Ho P . Specific association of human telomerase activity with immortal cells and cancer. Science. 1994; 266(5193):2011-5. DOI: 10.1126/science.7605428. View

17.

Antal T, Blagoev K, Trugman S, Redner S . Aging and immortality in a cell proliferation model. J Theor Biol. 2007; 248(3):411-7. PMC: 2265559. DOI: 10.1016/j.jtbi.2007.06.009. View

18.

Olofsson P, Bertuch A . Modeling growth and telomere dynamics in Saccharomyces cerevisiae. J Theor Biol. 2009; 263(3):353-9. PMC: 3832845. DOI: 10.1016/j.jtbi.2009.12.004. View

19.

Richter T, von Zglinicki T . A continuous correlation between oxidative stress and telomere shortening in fibroblasts. Exp Gerontol. 2007; 42(11):1039-42. DOI: 10.1016/j.exger.2007.08.005. View

20.

Wright W, Piatyszek M, Rainey W, Byrd W, Shay J . Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 1996; 18(2):173-9. DOI: 10.1002/(SICI)1520-6408(1996)18:2<173::AID-DVG10>3.0.CO;2-3. View